Exploring 5-MeO-DIPT. To explore a different substance…

Names:
5-MeO-DIPT · 3-[2-(Diisopropylamino)ethyl]-5-methoxyindole · N,N-Diisopropyl-5-methoxytryptamine · Indole, 3-[2-(diisopropylamino)ethyl]-5-methoxy · Tryptamine, N,N-diisopropyl-5-methoxy
IUPAC name:
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-(propan-2-yl)propan-2-amine
ID: 5037 · Formula: C17H26N2O · Molecular weight: 274.401
InChI: InChI=1S/C17H26N2O/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17/h6-7,10-13,18H,8-9H2,1-5H3

McKenna, DJ. Monoamine oxidsase inhibitors in Amazonian hallucinogenic plants: Ethnobotanical, phytochemical, and pharmacological investigations. Ph. D. Thesis, University of British Columbia, BC, Canada, 26 Apr 1984. 12.2 MB.

Brandt, SD; Freeman, S; Fleet, IA; Alder, JF. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part III. Characterisation of the Speeter and Anthony route to N,N-dialkylated tryptamines using CI-IT-MS-MS. Analyst, 1 Jan 2005, 130 (9), 1258–1262. 250 kB. http://dx.doi.org/10.1039/b504001a

Meatherall, R; Sharma, P. Foxy, a designer tryptamine hallucinogen. J. Anal. Toxicol., 1 Jul 2003, 27 (5), 313–317. 988 kB. http://dx.doi.org/10.1093/jat/27.5.313

Kamata, T; Katagi, M; Kamata, HT; Miki, A; Shima, N; Zaitsu, K; Nishikawa, M; Tanaka, E; Honda, K; Tsuchihashi, H. Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: Identification and quantification of its urinary metabolites. Drug Metab. Dispos., 1 Feb 2006, 34 (2), 281–287. 427 kB. http://dx.doi.org/10.1124/dmd.105.005835

Ray, TS. Psychedelics and the human receptorome. PLOS ONE, 2 Feb 2010, 5 (2), e9019. 791 kB. http://dx.doi.org/10.1371/journal.pone.0009019

Shulgin, AT; Carter, MF. N,N-diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity. Commun. Psychopharmacol., 1 Jan 1981, 4 (5), 363–369. 1.2 MB.

Shulgin, AT. 5-Methoxy-N-ethyl-N-isopropyltryptamine, 5-MeO-MIPT, 5-MeO-DIPT, 5-MeO-EIPT. Ask Dr. Shulgin Online, Center for Cognitive Liberty & Ethics, 27 Feb 2002.

Rodriguez-Cruz, SE. Analysis and characterization of designer tryptamines using electrospray ionization mass spectrometry (ESI-MS). Microgram J., 1 Jul 2005, 3 (3–4), 107–129. 1.6 MB.

Spratley, TK; Hays, PA; Geer, LC; Cooper, SD; McKibben, TD. Analytical profiles for five “designer” tryptamines. Microgram J., 1 Jan 2005, 3 (1–2), 54–68. 473 kB.

Brandt, SD; Freeman, S; Fleet, IA; McGagh, P; Alder, JF. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part II. Characterisation of the Speeter and Anthony synthetic route to N,N-dialkylated tryptamines using GC-EI-ITMS, ESI-TQ-MS-MS and NMR. Analyst, 2005, 130 (3), 330–344. 403 kB. http://dx.doi.org/10.1039/b413014f

Brandt, SD; Freeman, S; Fleet, IA; McGagh, P; Alder, JF. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS. Analyst, 2004, 129 (11), 1047–1057. 420 kB. http://dx.doi.org/10.1039/b407239c

Blough, BE; Landavazo, A; Decker, AM; Partilla, JS; Baumann, MH; Rothman, RB. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacology, 1 Oct 2014, 231 (21), 4135-4144. 298 kB. http://dx.doi.org/10.1007/s00213-014-3557-7

Meyer, MR; Caspar, A; Brandt, SD; Maurer, HH. A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches. Anal. Bioanal. Chem., 1 Jan 2014, 406 (1), 225–237. 457 kB. http://dx.doi.org/10.1007/s00216-013-7425-9

Brandt, SD; Tirunarayanapuram, SS; Freeman, S; Dempster, N; Barker, SA; Daley, PF; Cozzi, NV; Martins, CPB. Microwave-accelerated synthesis of psychoactive deuterated N,N-dialkylated-[α,α,β,β-d4]-tryptamines. J. Labelled Compd. Radiopharm., 1 Nov 2008, 51 (14), 423–429. 169 kB. http://dx.doi.org/10.1002/jlcr.1557

McKenna, DJ; Repke, DB; Lo, L; Peroutka, SJ. Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology, 1 Mar 1990, 29 (3), 191–198. 679 kB. http://dx.doi.org/10.1016/0028-3908(90)90001-8

Wilson, JM; McGeorge, F; Smolinske, S; Meatherall, R. A foxy intoxication. Forensic Sci. Int., 1 Jan 2005, 148 (1), 31–36. 160 kB. http://dx.doi.org/10.1016/j.forsciint.2004.04.017

Brandt, SD; Martins, CP. Analytical methods for psychoactive N,N-dialkylated tryptamines. Trends Anal. Chem., 1 Sep 2010, 29 (8), 858–869. 446 kB. http://dx.doi.org/10.1016/j.trac.2010.04.008 #34

Tanaka, E; Kamata, T; Katagi, M; Tsuchihashi, H; Honda, K. A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy. Forensic Sci. Int., 1 Jan 2006, 163 (1), 152–154. 105 kB. http://dx.doi.org/10.1016/j.forsciint.2005.11.026

Nakanishi, K; Miki, A; Zaitsu, K; Kamata, H; Shima, N; Kamata, T; Katagi, M; Tatsuno, M; Tsuchihashi, H; Suzuki, K. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Sci. Int., 10 Apr 2012, 217 (1–3), 174–181. 397 kB. http://dx.doi.org/10.1016/j.forsciint.2011.11.003

Halberstadt, AL; Geyer, MA. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology, 1 Sep 2011, 61 (3), 364–381. 817 kB. http://dx.doi.org/10.1016/j.neuropharm.2011.01.017

Chen, B; Liu, J; Chen, W; Chen, H; Lin, C. A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation. Talanta, 15 Jan 2008, 74 (4), 512–517. 486 kB. http://dx.doi.org/10.1016/j.talanta.2007.06.012

Melatonin
5-MeO-DET
5-MeO-DMT
5-MeO-MIPT
5-MeO-NMT
5-MeO-DPT
5-MeO-NCPT
5-MeO-T
N-Hexanoyl-5-MeO-T
N-Octanoyl-5-MeO-T
N-Heptafluorobutyroyl-5-MeO-T
5-MeO-DALT
5MT-NBOMe · 5MT-NB2OMe
5-MeO-EIPT
5-MeO-NALT
5-MeO-DPRT
5-MeO-MET
5MT-NB
5MT-NBOH
5MT-NB2OTFM
5MT-NB4OMe
5MT-NB4NO2
5MT-NB4NH2
5MT-NB4Me
5MT-NB4I
5-MeO-NBpBrT · 5MT-NB4B
5MT-NB4Cl
5MT-NB4F
5-MeO-NET
428
427
5-MeO-NIPT
5-MeO-MPT
5-MeO-EPT
5-MeO-DIBT
5-MeO-DBT
5-MeO-MIBT
5655
5657
5658
5659
5660
5661
5662
5663
5664
5665
5666
5667
5668
5669
5670
5671
5672
5673
5674
5675
5676
5677
5678
5679
5680
5681
5682
5683
5684
5685
5686
5687
5688
5689
5690
5691
5692
5694
5-MeO-MALT
5696
5697
5698
Methyl N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylglycinate
tert-Butyl N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylglycinate
N2-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N2-methylglycinamide
5712
5713
5MT-NB3TFM
5MT-NB3Me
5MT-NB3I
5MT-NB3Cl
5MT-NB3F
5MT-NB3B
5MT-NB2B · 5MT-NBBr
5MT-NB3OMe
5MT-NB3SMe
5-MeO-2-Me-DIPT
DIPT
5-HO-DIPT
5-EtO-DIPT
5-Cam-DIPT
5-MeO-pyr-T
5-MeO-mor-T
5-MeO-pip-T
5-MeO-ICPA
5-MeO-DPT
4-MeO-DIPT
7-MeO-DIPT
5-EtO-MPT
5-EtO-EIPT
5-MeO-2-Me-EPT
5-MeO-2-Me-EIPT
5686
5-iPrO-DET
5-PrO-DET
5-HeO-NMT
Melatonin
5-MeO-DET
5-MeO-DMT
5-MeO-MIPT
5-MeO-NMT
5-MeO-DPT
5-MeO-NCPT
5-MeO-T
N-Hexanoyl-5-MeO-T
N-Octanoyl-5-MeO-T
N-Heptafluorobutyroyl-5-MeO-T
5-MeO-DALT
5MT-NBOMe · 5MT-NB2OMe
5-MeO-EIPT
5-MeO-NALT
5-MeO-DPRT
5-MeO-MET
5MT-NB
5MT-NBOH
5MT-NB2OTFM
5MT-NB4OMe
5MT-NB4NO2
5MT-NB4NH2
5MT-NB4Me
5MT-NB4I
5-MeO-NBpBrT · 5MT-NB4B
5MT-NB4Cl
5MT-NB4F
5-MeO-NET
428
427
5-MeO-NIPT
5-MeO-MPT
5-MeO-EPT
5-MeO-DIBT
5-MeO-DBT
5-MeO-MIBT
5655
5657
5658
5659
5660
5661
5662
5663
5664
5665
5666
5667
5668
5669
5670
5671
5672
5673
5674
5675
5676
5677
5678
5679
5680
5681
5682
5683
5684
5685
5686
5687
5688
5689
5690
5691
5692
5694
5-MeO-MALT
5696
5697
5698
Methyl N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylglycinate
tert-Butyl N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylglycinate
N2-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N2-methylglycinamide
5712
5713
5MT-NB3TFM
5MT-NB3Me
5MT-NB3I
5MT-NB3Cl
5MT-NB3F
5MT-NB3B
5MT-NB2B · 5MT-NBBr
5MT-NB3OMe
5MT-NB3SMe
5-MeO-2-Me-DIPT
DIPT
5-HO-DIPT
5-EtO-DIPT
5-Cam-DIPT
5-MeO-pyr-T
5-MeO-mor-T
5-MeO-pip-T
5-MeO-ICPA
5-MeO-DPT
4-MeO-DIPT
7-MeO-DIPT
5-EtO-MPT
5-EtO-EIPT
5-MeO-2-Me-EPT
5-MeO-2-Me-EIPT
5686
5-iPrO-DET
5-PrO-DET
5-HeO-NMT
24 November 2017 · Creative Commons BY-NC-SA ·